To the Editor,We read with interest a report in the present journal on the treatment of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in critically ill patients [1]. With a baseline ...
No takes yet. Share an insight, caveat, or question.
Venugopalan et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: